Macrolide Synthesis via Modular Coupling for Antibiotic Stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Emerging resistance to antibiotics, particularly in Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae, poses a global health crisis due to rapid gene transmission and inadequate new antibiotic development, with existing macrolides facing challenges like acid instability and resistance mechanisms.

Innovation Solution

A fully synthetic route for making macrolides through the coupling of western and eastern halves, allowing for various linkages and modifications such as Wittig or Homer-Emmons reactions, to produce compounds with improved stability and efficacy against resistant bacteria.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If macrolides are prepared through semi-synthesis from fermentation products, then the structural complexity is managed, but the manufacturing route becomes lengthy (up to 16 steps) and less efficient

Engineering Contradiction:
Improvemanufacturing route efficiencyVSAvoidsynthesis route complexity
Core Design Contradiction:
Ease of manufactureVSDevice complexity

Solution Approach 1:

The patent applies segmentation by dividing the macrolide molecule into distinct modular components (e.g., the 14-membered lactone ring system and side chain substituents) that can be synthesized and assembled separately. This modular approach enables more efficient construction of complex macrolide structures compared to traditional step-by-step semi-synthesis from natural products.

Inventive Principle:
Principle #1Segmentation

2Reliability

If erythromycin is used to treat bacterial infections, then antibacterial activity is achieved, but acid-promoted internal ketalization occurs leading to adverse gastrointestinal events

Engineering Contradiction:
Improveantibacterial efficacyVSAvoidgastrointestinal adverse events
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies local quality by introducing specific chemical modifications at particular positions on the macrolide ring structure (such as cladinose substitution or keto-group modifications) to locally alter the molecule's chemical stability and resistance to acid-promoted ketalization, thereby reducing gastrointestinal side effects while preserving antibacterial activity.

Inventive Principle:
Principle #3Local quality

3Stability of the object's composition

If macrolide structure is modified to improve acid stability, then gastrointestinal tolerance improves, but the ability to address emerging antibiotic resistance may be compromised

Engineering Contradiction:
Improveacid stabilityVSAvoideffectiveness against resistant bacteria
Core Design Contradiction:
Stability of the object's compositionVSAdaptability or versatility

Solution Approach 1:

The patent applies parameter changes by systematically varying chemical parameters such as ring size (14-, 15-, or 16-membered macrolides), substituent types (cladinose, keto groups, fluorine atoms), and side chain configurations to optimize both acid stability and antibacterial spectrum, enabling the development of macrolides that simultaneously improve gastrointestinal tolerance and maintain or enhance activity against resistant organisms.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS11634449B2Macrolides and methods of their preparation and use
Publication Date: 2023.04.25 PRESIDENT & FELLOWS OF HARVARD COLLEGE
  • US11634449B2 patent drawing
  • US11634449B2 patent drawing
  • US11634449B2 patent drawing

AI summary

Provided herein are methods of preparing macrolides by the coupling of an eastern and western half, followed by macrocyclization, to provide macrolides, including both known and novel macrolides. Intermediates in the synthesis of macrolides including the eastern and western halves are also provided. Pharmaceutical compositions and methods of treating infectious diseases and inflammatory conditions using the inventive macrolides are also provided. A general diastereoselective aldol methodology used in the synthesis of the western half is further provided.